Jo ChienJune 27, 2019
Mariana Chavez MacGregorJanuary 24, 2019
Stephen Chia, Canada
Stephen Chia MD, FRCPC
Dr. Stephen Chia
is currently co-chair of the Breast Disease Site of the Canadian Cancer Trials Group, a member of the CCTG Breast Executive Committee, the CCTG IND Executive Committee, and the CCTG Breast Correlative Science Committee. He is also a member of the NCI (National Cancer Institute) Breast Cancer Steering Committee of the NIH (US) sponsored NCTN (National Clinical Trials Network). He was a past member of the American Society of Clinical Oncology (ASCO) Scientific Committee (2009 to 2012), ASCO Breast Symposium Committee (2014-2015) and served as the Breast Track chair (Triple Negative/Cytotoxic/Local) for the ASCO 2011 Annual Meeting. He is an active researcher in phase 1 to 3 trials in breast cancer and investigational new drugs. He has an established interest in neoadjuvant systemic therapy for breast cancer and drug development and spearheaded the efforts for the BCCA – VCC to be the first Canadian site for the I-SPY2 consortium. He is currently carrying out clinical and translational studies in breast cancer with peer-reviewed, grant-funded research from the NCIC, National Institutes of Health (USA), Canadian Breast Cancer Research Alliance, and the Canadian Breast Cancer Foundation.